Jump to content

Pridinol

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 15:34, 17 October 2022 (The usual sock, with the usual uncited analysis, non-reliable sources, etc). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Pridinol
Clinical data
Trade namesMyopridin
AHFS/Drugs.comInternational Drug Names
Routes of
administration
By mouth, parenteral
ATC code
Legal status
Legal status
  • UK: POM (Prescription only)
Identifiers
  • 1,1-Diphenyl-3-(piperidin-1-yl)propan-1-ol
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.007.390 Edit this at Wikidata
Chemical and physical data
FormulaC20H25NO
Molar mass295.426 g·mol−1
  • InChI=1S/C20H25NO/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1-2,4-7,10-13,22H,3,8-9,14-17H2 checkY
  • Key:RQXCLMGKHJWMOA-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Pridinol, sold under the brand name Myopridin, is a muscle relaxant that is used as an antiparkinsonian and anticholinergic drug.[1]

It was approved for medical use in the UK in May 2020.[2]

References

  1. ^ Budavari S, ed. (1989). The Merck index an encyclopedia of chemicals, drugs, and biologicals (11th ed., 2nd print. ed.). Rahway, NJ: Merck. p. 7747. ISBN 091191028X.
  2. ^ "Pridinol". SPS - Specialist Pharmacy Service. 10 August 2020. Retrieved 21 August 2020.
  • "Pridinol". Drug Information Portal. U.S. National Library of Medicine.